[PDF] Top 20 Ribavirin-induced anemia in hepatitis C virus patients undergoing combination therapy.

... for hepatitis C virus (HCV) infection – combination therapy with pegylated interferon and ribavirin – elicits sustained responses in only ,50% of the patients ... See full document

... Interestingly, in the study by Rotman et ...decline in HCV RNA among IL28B CC/CT carriers as compared to IL28B TT receiving ribavirin mono-therapy, as well as a significantly greater decline ... See full document

... severe anemia among patients with chronic hepatitis C virus (HCV) genotype 1 infection, treated with first-generation protease inhibitor (PI)-based ...all patients who initiated ... See full document

... Antiviral treatment was the standard of care, with weekly pegylated interferon alfa-2a (180 ug) or alfa-2b (1.5 ug/kg) plus ribavirin (0.8–1.2 g daily) for 24 or 48 weeks, according to HCV genotype. The use of ... See full document

... against ribavirin (RBV)-induced anaemia in European, American and Asian patients; however, there is a paucity of data for Brazilian ...frequency in healthy and hepatitis C ... See full document

... of hepatitis C in patients coinfected with human immunodeiciency virus ...20 patients coinfected with HIV-1/HCV who were treated in the outpatient liver clinic at the ... See full document

... HCV- induced cryglobulinemic MPGN with ribavirin alone, and observed an improvement of hepatic and renal disease at the end of the ...increase in proteinuria, and the ALT levels became similar to ... See full document

... two hepatitis C virus genome regions previously postulated to be involved in the viral response to combined antiviral ...regions in the envelope E2 glycoprotein, and the other ... See full document

... all patients, antiviral treatment was initiated at one to three months after ...48-week combination therapy regimen was assigned according to the HCV ...genotype. Patients infected with HCV ... See full document

... between hepatitis C virus infection, iron homeostasis and the response to antiviral treatment remains ...antiviral therapy in patients with chronic hepatitis ...50 ... See full document

... Introduction: In 2013, combination therapy using peginterferon, ribavirin, and boceprevir or telaprevir was introduced to treat hepatitis C virus genotype 1 infection ... See full document

... infected hepatitis C virus (HCV) ...thrombocytopenic patients (group I), 14 HCV-positive non-thrombocytopenic patients (group II) and 15 healthy controls (group III), 11 ... See full document

... the in vitro production of anti-HCV anti- bodies in patients with chronic HCV infec- tion, showed an association between elevated antibody levels and male sex, elevated ALT level, and more advanced ... See full document

... limited. In this study, serum samples were obtained from a child and his ...found in the father and ayw1, adw2 and adwq+ in the mother; adrq+ was the only serotype in ...identified in ... See full document

... among patients with CHC ...increase in patients with cirrhosis ...progression in CHC patients particularly focusing on the presence of hepatocellular ...among patients with ... See full document

... A utilização do interferon- α (INF-α) como tratamento para a Hepatite C iniciou por volta de 1986, antes mesmo da descoberta do agente etiológico da doença. Foi utilizado primeiramente como uma monoterapia, o que ... See full document

... of Hepatitis B Virus infection in women with epithelial ovarian ...from patients with histologically proven EOC using consensus ...HBV-DNA in cancerous ovarian tissues. All of the ... See full document

... observed in approximately half of the treated patients and many factors, such as age, genotype, viral load and body weight, are related to treatment outcome (Manns et ...response in chronically ... See full document

... Polymorphisms in the IL-10 (-1082 A/G, rs1800896), TNF (-308 G/A, rs1800629 and -238 G/A, rs361525) and Mx1 (-123 C/A, rs17000900 and -88 G/T, rs2071430) gene promoters were ...cited in the ... See full document

... Long-term outcome In Kidney transplant patients with hepatitis C (HCV ) infection. Prevalence of antibodies to hepatitis C virus among hemodialysis patients in Damascus. Home hemodialy[r] ... See full document